Quinoa (Chenopodium quinoa)
Quinoa is the seed of Chenopodium quinoa, an Andean pseudocereal cooked like a grain and sold as whole seed, flakes, flour, protein powders and seed extracts, some standardized to 20-hydroxyecdysone. Per 100 g uncooked, USDA lists about 14 g of protein, 7 g of fiber, and its seed coat carries bitter saponins that washing removes. In a double-blind trial in older adults, quinoa biscuits lowered total and LDL cholesterol slightly more than matched wheat biscuits, but quinoa bread and boiled quinoa did not lower blood lipids more than the comparison grains. Two trials in people with raised blood sugar reported better glucose measures, but one was unblinded and used blended quinoa products and the other did not report blinding or registration. Quinoa is naturally gluten-free and was tolerated by 19 people with celiac disease over 6 weeks, though 2 of 15 cultivars triggered celiac immune responses in lab tests. Allergy has been reported.
Benefits
Total and LDL cholesterol in older adults eating quinoa biscuits
In a double-blind crossover trial in 40 adults aged 50 to 75, most with total cholesterol above 5 mmol/L, quinoa biscuits for 4 weeks lowered total cholesterol by 0.30 and LDL by 0.25 mmol/L more than matched wheat biscuits. Bread with 20 g of quinoa flour a day in 30 men, and 40 g a day of boiled quinoa against other grains, did not lower blood lipids more than the comparison.
Triglyceride levels with 50 g of quinoa seed a day
In 50 adults with overweight or obesity, 50 g a day of quinoa for 12 weeks left triglycerides lower than in a group that ate no quinoa (0.72 versus 1.25 mmol/L), while 25 g a day did not. Total, LDL and HDL cholesterol, body composition and fasting glucose did not change. The comparison group received no matched food.
Blood sugar measures when quinoa replaces part of staple foods
In a one-year trial in 207 adults with impaired glucose tolerance, 100 g a day of quinoa in place of about half the staple food gave lower 2-hour glucose and fasting insulin than a multigrain diet or control, while HbA1c improved in both grain groups. In early type 2 diabetes, blended products with 15 to 20 percent quinoa lowered HbA1c more than a matched diet.
Smaller blood sugar rise after a quinoa meal than after white bread
In 18 healthy young women, cooked quinoa (36 or 50 g dry) gave a lower 2-hour blood sugar response than white bread with the same available carbohydrate, and lower desire to eat at later time points. This was a single-meal test. A pooled analysis of 7 trials found no effect of quinoa on body weight or BMI.
Liver fat score when quinoa replaces lunch grains
In 46 adults with fatty liver on reduced-calorie diet plans, about 50 g of quinoa in place of lunch grains for 12 weeks lowered the liver fat score (CAP), the main outcome, and LDL cholesterol more than usual grains, even after adjusting for weight. Liver enzymes did not differ. Participants were not blinded and the quinoa group lost more weight.
Plant protein and minerals in a gluten-free seed
Per 100 g uncooked, USDA lists 14.1 g of protein (0.77 g of it lysine), 7.0 g of fiber, 197 mg of magnesium and 4.6 mg of iron. In 19 people with celiac disease, 50 g a day for 6 weeks was tolerated without worsening the condition, though in lab tests 2 of 15 cultivars activated celiac immune cells at levels similar to gliadin.
Mechanism of action
Starch, fiber and protein
Quinoa is mostly starch (about 52 g per 100 g uncooked) with 7 g of fiber and 14 g of protein. Researchers propose that its fiber, slowly digested starch and protein slow carbohydrate digestion and prolong fullness, which would fit the smaller post-meal glucose rise seen against white bread. This mechanism has not been measured directly in people.
20-hydroxyecdysone and other phytoecdysteroids
Quinoa seeds contain ecdysteroids, mainly 20-hydroxyecdysone, measured at 491 micrograms per gram in one analysis; a concentrated seed leachate lowered fasting glucose in obese, hyperglycemic mice. When 8 people ate about 368 g of cooked quinoa, about 2.6 percent of the ecdysterone was recovered in urine, which the authors read as poor bioavailability.
Saponins in the seed coat
Bitter triterpene saponins sit in the outer layer of the seed and have to be removed before eating. In one processing study, three short alkaline washes cut saponin content by about 66 percent without changing protein, starch or phenolic content. Saponins are not credited with any shown effect in people.
Clinical trials
Randomized, double-blind crossover trial; 15 g a day of quinoa biscuits (60 g quinoa flour per 100 g) or iso-energetic wheat flour biscuits for 4 weeks each with a 6 week washout; registered NCT03291548 after the study ended, with total cholesterol as the primary outcome; funding not stated in the abstract or registry (Pourshahidi et al. 2020, Eur J Nutr)
40 free-living healthy adults aged 50 to 75; 33 (82.5 percent) had total cholesterol above 5 mmol/L at the start; none were lost to follow-up.
Total cholesterol fell 0.30 and LDL cholesterol 0.25 mmol/L more after quinoa than after control biscuits, with small greater falls in the total to HDL cholesterol ratio, weight (0.61 kg) and BMI (all P < 0.05). Triglycerides, HDL cholesterol, PUFA and CRP did not differ between treatments, and habitual diet and activity did not change.
Randomized crossover trial without masking; one wheat roll a day providing 20 g of quinoa flour or a refined wheat roll for 4 weeks each with a 4 week washout; registered NCT03036618 in January 2017, about five months after the August 2016 start (the paper says before), with LDL cholesterol as the primary outcome; funded by a Chinese Government Postgraduate Scholarship (Li et al. 2018, Nutrients)
37 healthy overweight men randomized (30 completed), average age 52, in Newcastle, UK.
LDL cholesterol, the primary outcome, and fasting glucose fell in both periods with no difference between quinoa and wheat bread, and body measures and other blood markers did not differ. On continuous glucose monitoring, cumulative glucose over the last 4 days was lower than in the matching wheat period (p = 0.039), a secondary result. Both breads were well tolerated.
Randomized, open-label, active-comparator trial in four parallel groups; 40 g a day of boiled red quinoa, buckwheat, rice or bulgur added to the usual diet for 4 weeks; glucose, insulin, lipids, blood pressure, BMI and fat mass were primary outcomes; registered retrospectively as NCT07513610 in March 2026; funded by Hacettepe University (Oztekin et al. 2026, Metabolites)
148 adults aged 25 to 45 with overweight or obesity in Ankara, Turkey.
Changes in biochemical and body measures did not differ significantly between the four groups. Within the quinoa group, fat mass fell, fasting glucose fell in men only, and total cholesterol fell in men but rose in women, while HDL cholesterol fell in women. Mild digestive symptoms in the first week were reported by 2 people on quinoa and by 1 to 3 people in each other group.
Randomized, controlled parallel trial with blinded outcome assessors; 25 or 50 g a day of quinoa seed in sachets, cooked at home, or no quinoa for 12 weeks; lipid profile was the primary outcome; registered as UTN U1111-1175-470; the authors report no funding (Navarro-Perez et al. 2017, Curr Dev Nutr)
50 completers (of 64 randomized) aged 20 to 64 with BMI above 25, without diabetes, heart disease or lipid-lowering medication, at La Trobe University, Australia.
Triglycerides were lower in the 50 g group than in controls at 12 weeks (0.72 versus 1.25 mmol/L, P = 0.022); the 25 g dose did not differ. Total, LDL and HDL cholesterol, fasting glucose, body composition, hormones and reported energy intake did not change. The control group ate no matched food.
Randomized controlled trial; 100 g a day of quinoa replacing about half of daily staple food, 100 g a day of a whole grain blend, or control for one year; the abstract does not state the primary outcome, blinding, registration or funding (Huang et al. 2025, Food Funct)
207 adults diagnosed with impaired glucose tolerance in Guangzhou, China.
At one year the quinoa group had longer time in the target glucose range, more conversion to normal glucose tolerance, and lower 2-hour glucose, fasting insulin, HOMA-IR and 14-day mean glucose than both the multigrain and control groups (P < 0.05). HbA1c improved in both grain groups compared with control, and glucose variability did not differ between quinoa and control.
Randomized, open-label parallel trial; noodles, blended powder and cookies containing 15 to 20 percent quinoa plus legumes and other grains replaced staple foods, against a regular diet matched for energy and macronutrients; primary endpoints were glucose reduction and stability; the paper cites NCT06156137, which is an unrelated observational registry record, and the matching record NCT07329231 was first submitted in June 2025 after a January 2021 start, with no masking; funded by Shandong University (Zhang et al. 2026, Int J Gen Med)
60 adults (56 analyzed) with type 2 diabetes for less than 5 years and HbA1c of 6.5 to 10 percent, not on insulin, in Jinan, China.
HbA1c fell 0.86 versus 0.28 points (P = 0.042) and post-meal glucose fell 4.57 versus 2.2 mmol/L (P < 0.001) more on the quinoa products, with more time in the target range (94.5 versus 87.8 percent) and more people reducing or stopping medication (28.6 versus 7.1 percent). Pure quinoa intake averaged about 22 g a day, and because the products were blends, the result cannot be assigned to quinoa alone.
Randomized controlled parallel trial; participants not blinded, outcome assessors blinded; about 50 g of quinoa replacing lunch grains versus usual grains, with diet plans set 500 kcal a day below needs; primary outcome the CAP liver fat score; registered IRCT20100524004010N37; funded by Shahid Beheshti University of Medical Sciences (Gholamrezayi et al. 2025, Front Nutr)
46 adults with fatty liver (CAP above 263) and an average BMI of about 32, in Tehran, Iran; analyzed by intention to treat.
CAP fell 32.3 versus 13.8 points (p = 0.044) and stayed significant after adjusting for weight change, and LDL cholesterol and HOMA-IR also improved more than control after that adjustment. Weight fell 3.1 versus 0.5 kg. Liver enzymes, liver stiffness, fasting glucose, total and HDL cholesterol and hs-CRP did not differ.
Single-group open study without a control group; 50 g of quinoa a day added to the usual gluten-free diet for 6 weeks (Zevallos et al. 2014, Am J Gastroenterol)
19 treated adults with celiac disease in London, UK; 10 had intestinal biopsies before and after.
Gastrointestinal measures stayed normal and quinoa did not worsen the condition. In the 10 biopsied patients the villus height to crypt depth ratio moved from 2.8:1 to 3:1, and blood tests stayed within normal ranges, with total cholesterol going from 4.6 to 4.3 mmol/L. The study was small and uncontrolled, and long-term effects were not tested.
Side effects and drug interactions
Common Potential side effects
Important Drug interactions
Frequently asked questions about Quinoa (Chenopodium quinoa)
Is quinoa a grain?
Botanically it is a seed. Quinoa is a pseudocereal from the Andes that is cooked and eaten like a grain and milled into flour and flakes. It is naturally gluten-free and, per USDA, supplies about 14 g of protein and 7 g of fiber per 100 g uncooked.
Does quinoa lower cholesterol?
Results differ by trial. In a double-blind trial in older adults, quinoa biscuits for 4 weeks lowered total cholesterol by 0.30 and LDL by 0.25 mmol/L more than matched wheat biscuits. A quinoa bread trial found no LDL difference against wheat bread, and 40 g a day of boiled quinoa did not change lipids compared with rice, bulgur or buckwheat.
Is quinoa a meaningful source of ecdysterone?
Quinoa contains 20-hydroxyecdysone, about 491 micrograms per gram of seed in one analysis, but when 8 people ate about 368 g of cooked quinoa only about 2.6 percent appeared in urine. Extracts standardized to the compound concentrate it; trials of the isolated compound are covered under Ecdysterone. Ecdysterone has been on the World Anti-Doping Agency monitoring list since 2020.
Do I need to rinse quinoa?
Unwashed quinoa tastes bitter because of saponins in the seed coat. Washing removes them: in one processing study, three alkaline washes cut saponins by about 66 percent without changing protein or starch content.
Does quinoa help with weight?
Not clearly. A pooled analysis of 7 trials found no effect on body weight or BMI. Quinoa biscuits gave 0.61 kg more weight loss than wheat biscuits over 4 weeks, and in a 12 week trial on reduced-calorie plans the quinoa group lost 3.1 kg versus 0.5 kg, but that trial was not blinded.
What is Quinoa?
Quinoa is the seed of Chenopodium quinoa, an Andean pseudocereal cooked like a grain and sold as whole seed, flakes, flour, protein powders and seed extracts, some standardized to 20-hydroxyecdysone.
What is Quinoa used for?
NutraSmarts does not list Quinoa under a health category. What the research covers: In a double-blind crossover trial in 40 adults aged 50 to 75, most with total cholesterol above 5 mmol/L, quinoa biscuits for 4 weeks lowered total cholesterol by 0.30 and LDL by 0.25 mmol/L more than matched wheat biscuits.
What is the recommended dosage of Quinoa?
The clinically studied dose is 15 g a day of quinoa biscuits (60 g quinoa flour per 100 g) or 20 g of quinoa flour in bread for 4 weeks; 25 to 50 g a day of seed for 12 weeks; 50 g a day for 6 weeks in a celiac tolerance study; 100 g a day replacing staple food for one year. Always follow the product label and check with a healthcare provider for personal advice.
Is Quinoa safe, and does it have side effects?
Side effects and cautions reported for Quinoa include: Allergy: a 2024 review of anaphylaxis triggers lists pseudograins, including quinoa, among food allergens on the rise. Avoid quinoa if you have reacted to it. It may also interact with some medications. Quinoa is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.
Does Quinoa interact with any medications?
Possible interactions include: Diabetes medicines: in trials in people with raised blood sugar, quinoa diets lowered glucose measures, and in one trial more people reduced their medication. Monitor glucose and involve your prescriber when quinoa becomes a large part of the diet. If you take prescription medication, check with a pharmacist or doctor before using it.
How strong is the scientific evidence for Quinoa?
NutraSmarts rates the evidence for Quinoa as Limited (2 out of 5). It is backed by 8 study summaries and 16 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.
References(16 citations)
Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.
- Modest improvement in CVD risk markers in older adults following quinoa (Chenopodium quinoa Willd.) consumption: a randomized-controlled crossover study with a novel food product. Eur J Nutr. 2020;59(7):3313-3323. doi: 10.1007/s00394-019-02169-0.PubMedUsed to support: Randomized, double-blind crossover trial in 40 healthy adults aged 50 to 75 (33 with total cholesterol above 5 mmol/L): 15 g a day of quinoa biscuits (60 g quinoa flour per 100 g) or iso-energetic wheat biscuits for 4 weeks each, 6 week washout. Total and LDL cholesterol fell more after quinoa (0.30 and 0.25 mmol/L), as did the total to HDL ratio, weight (0.61 kg) and BMI (all P < 0.05); triglycerides, HDL, PUFA and CRP did not differ. Registry NCT03291548 (posted after completion) lists total cholesterol as the primary outcome and two 15 g biscuits a day.
- Effects of Quinoa (Chenopodium quinoa Willd.) Consumption on Markers of CVD Risk. Nutrients. 2018;10(6):777. doi: 10.3390/nu10060777.PubMedUsed to support: Randomized crossover trial in 37 healthy overweight men (30 completed): a wheat roll providing 20 g of quinoa flour a day versus a refined wheat roll, 4 weeks each with a 4 week washout. The primary outcome, LDL cholesterol, did not differ between breads; glucose and LDL fell in both periods. Cumulative glucose on continuous monitoring over the last 4 days was lower than in the wheat period (p = 0.039). Both breads were well tolerated. Registered NCT03036618 in January 2017, after the August 2016 start; funded by a Chinese Government Postgraduate Scholarship.
- Comparative Effects of Quinoa, Buckwheat, Bulgur, and Rice on Cardiometabolic Health in Adults with Overweight or Obesity: A Randomized Controlled Study. Metabolites. 2026;16(9):628. doi: 10.3390/metabo16090628.PubMedUsed to support: Randomized, open-label, active-comparator trial in 148 adults aged 25 to 45 with overweight or obesity: 40 g a day of boiled quinoa, buckwheat, rice or bulgur for 4 weeks. Changes in biochemical and body measures did not differ significantly between groups; within the quinoa group fat mass fell, fasting glucose fell in men, total cholesterol fell in men and rose in women, and HDL fell in women. Mild first-week digestive symptoms occurred in all groups. Registered retrospectively (NCT07513610, March 2026); funded by Hacettepe University.
- Quinoa Seed Lowers Serum Triglycerides in Overweight and Obese Subjects: A Dose-Response Randomized Controlled Clinical Trial. Curr Dev Nutr. 2017;1(9):e001321. doi: 10.3945/cdn.117.001321.PubMedUsed to support: Randomized, controlled, single-blind parallel trial in 50 overweight or obese adults (completers): 25 or 50 g a day of quinoa or no quinoa for 12 weeks, with lipid profile as the primary outcome. Triglycerides were lower with 50 g a day than in controls (0.72 versus 1.25 mmol/L, P = 0.022); total, LDL and HDL cholesterol, glucose, body composition and hormones did not change. The control group received no matched food. The authors report no funding.
- Quinoa is more effective than other whole grains in the management of impaired glucose tolerance: a randomized controlled trial. Food Funct. 2025;16(2):763-773. doi: 10.1039/d4fo04557b.PubMedUsed to support: Abstract read. Randomized trial in 207 adults with impaired glucose tolerance: 100 g a day of quinoa replacing about half of staple food, 100 g a day of a whole grain blend, or control for one year. The quinoa group had longer time in range, more conversion to normal glucose tolerance and lower 2-hour glucose, fasting insulin, HOMA-IR and 14-day mean glucose than the multigrain and control groups; HbA1c improved in both grain groups versus control. The abstract does not state the primary outcome, blinding, registration or funding.
- Quinoa Improves Glucose Metabolism and Fluctuation Based on β-Cell Function in Early-Stage Type 2 Diabetes Mellitus: A Randomized Study. Int J Gen Med. 2026;19:584727. doi: 10.2147/IJGM.S584727.PubMedUsed to support: Randomized, open-label trial in 60 adults with early type 2 diabetes: blended noodles, powder and cookies containing 15 to 20 percent quinoa replaced staple foods for about 12 weeks (pure quinoa about 22 g a day), against a regular diet matched for energy and macronutrients. HbA1c fell 0.86 versus 0.28 points (P = 0.042), post-meal glucose fell more (P < 0.001), time in range was higher and more patients reduced or stopped medication (28.6 versus 7.1 percent). The paper cites NCT06156137, an unrelated observational registry record; the matching record, NCT07329231, was submitted in June 2025, after the trial began. Funded by Shandong University.
- The effect of replacing grains with quinoa on cardiometabolic risk factors and liver function in patients with non-alcoholic fatty liver: a randomized-controlled clinical trial. Front Nutr. 2025;12:1505183. doi: 10.3389/fnut.2025.1505183.PubMedUsed to support: Randomized controlled trial in 46 adults with fatty liver: about 50 g of quinoa replacing lunch grains versus usual grains for 12 weeks within reduced-calorie plans; participants not blinded. The primary outcome, CAP liver fat score, fell more with quinoa (32.3 versus 13.8 points, p = 0.044), also after adjusting for weight change, as did LDL cholesterol and HOMA-IR; weight fell 3.1 versus 0.5 kg. Liver enzymes, liver stiffness, fasting glucose and hs-CRP did not differ. Registered IRCT20100524004010N37; university funded.
- Gastrointestinal effects of eating quinoa (Chenopodium quinoa Willd.) in celiac patients. Am J Gastroenterol. 2014;109(2):270-8. doi: 10.1038/ajg.2013.431.PubMedUsed to support: Single-group study in 19 treated adults with celiac disease who added 50 g of quinoa a day to their gluten-free diet for 6 weeks. Gastrointestinal measures stayed normal, biopsy measures in 10 patients improved slightly (villus to crypt ratio 2.8:1 to 3:1), blood tests stayed in normal ranges and total cholesterol went from 4.6 to 4.3 mmol/L. No control group.
- Variable activation of immune response by quinoa (Chenopodium quinoa Willd.) prolamins in celiac disease. Am J Clin Nutr. 2012;96(2):337-44. doi: 10.3945/ajcn.111.030684.PubMedUsed to support: Laboratory study of 15 quinoa cultivars: 4 had measurable celiac-toxic epitopes, below the limit for a gluten-free food, and 2 (Ayacuchana and Pasankalla) stimulated celiac intestinal T cells and cytokine release from celiac biopsy samples at levels similar to gliadin. Most cultivars lacked measurable celiac-toxic epitopes. Not a feeding study.
- Postprandial Glycemic and Satiety Responses to Cooked Quinoa: A Randomized Crossover Preliminary Study. Foods. 2026;15(15):2610. doi: 10.3390/foods15152610.PubMedUsed to support: Randomized crossover single-meal study in 18 healthy young women: cooked quinoa (36 or 50 g dry) versus white bread, each providing 25 or 35 g of available carbohydrate. Quinoa gave a lower 2-hour glucose response and incremental area under the curve at both amounts, and lower desire to eat at later time points; palatability and tolerance were similar. Funded by Kuwait University.
- Does Quinoa (Chenopodium quinoa) Consumption Improve Blood Glucose, Body Weight and Body Mass Index? A Systematic Review and Dose-Response Meta-Analysis of Clinical Trials. Curr Med Chem. 2024;31(4):502-513. doi: 10.2174/0929867330666230227151852.PubMedUsed to support: Meta-analysis of 7 trials (258 adults) using 15 to 50 g of quinoa a day for 28 to 180 days. Quinoa had no significant effect on body weight or BMI; the authors report a nonlinear dose-response relation with fasting glucose. A pooled analysis, not a new trial.
- Quinoa seeds leach phytoecdysteroids and other compounds with anti-diabetic properties. Food Chem. 2014;163:178-85. doi: 10.1016/j.foodchem.2014.04.088.PubMedUsed to support: Laboratory and mouse study: 20-hydroxyecdysone was the most prevalent phytoecdysteroid in quinoa seed (491 micrograms per gram), and an optimized ethanol leachate containing 0.86 percent 20-hydroxyecdysone lowered fasting glucose in obese, hyperglycemic mice. Two authors held equity in a company involved in quinoa research and development.
- Quinoa as phytopharmaceutical? Urinary elimination of ecdysterone after consumption of quinoa alone and in combination with spinach. Arch Pharm (Weinheim). 2024;357(6):e2300689. doi: 10.1002/ardp.202300689.PubMedUsed to support: Human excretion study in 8 people who ate about 368 g of cooked quinoa, alone and with spinach. Ecdysterone and two metabolites appeared in urine, but the total excreted was 2.61 percent of intake after quinoa, which the authors read as poor bioavailability. Notes that ecdysterone has been on the World Anti-Doping Agency monitoring list since 2020.
- Comparison of Grain Processing Techniques on Saponin Content and Nutritional Value of Quinoa (Chenopodium quinoa Cv. Yellow Pang-da) Grain. Pak J Biol Sci. 2021;24(7):821-829. doi: 10.3923/pjbs.2021.821.829.PubMedUsed to support: Processing study: quinoa saponins sit in the pericarp and cause bitterness, and are removed before eating. Washing three times in an alkaline solution (pH 8) for 8 minutes cut saponin content by about 66 percent without changing protein, flavonoid, starch or phenolic content.
- Emerging and Novel Elicitors of Anaphylaxis: Collegium Internationale Allergologicum Update 2024. Int Arch Allergy Immunol. 2024;185(8):794-802. doi: 10.1159/000537958.PubMedUsed to support: Review of emerging anaphylaxis triggers; lists pseudograins (buckwheat, quinoa) among food allergens on the rise, linked to growing demand for plant-based foods. A review, not a study of quinoa.
- FoodData Central: Quinoa, uncooked (SR Legacy, FDC ID 168874). USDA FoodData Central. 2019;SR Legacy food 20035..SourceUsed to support: Not PubMed-indexed; USDA nutrient database entry read via the FoodData Central API. Per 100 g of uncooked quinoa: 368 kcal, 14.12 g protein, 0.766 g lysine, 6.07 g fat, 64.16 g carbohydrate, 52.22 g starch, 7.0 g dietary fiber, 197 mg magnesium and 4.57 mg iron.